Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis

Overview of attention for article published in Drug Design, Development and Therapy, November 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 68 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

LOW VISCOSITY LIQUID FORMULATION COMPRISING HIGH CONCENTRATION ANTI-HUMAN INTERLEUKIN 23…

Application WO-2022041390-A1

World Intellectual Property Organisation (WIPO)